Operating Lease, Right-of-Use Asset of Immunocore Holdings plc from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Immunocore Holdings plc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
Immunocore Holdings plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $39,397,000, a 0.69% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Immunocore Holdings plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$39,397,000	-$275,000	-0.69%	30 Sep 2025	10-Q	06 Nov 2025	2025	Q3
Q2 2025	$39,428,000	+$6,993,000	+22%	30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	$38,126,000	+$5,314,000	+16%	31 Mar 2025	10-Q	07 May 2025	2025	Q1
Q4 2024	$37,643,000	+$4,123,000	+12%	31 Dec 2024	10-Q	06 Nov 2025	2025	Q3
Q3 2024	$39,672,000	+$34,172,000	+621%	30 Sep 2024	10-Q	06 Nov 2024	2024	Q3
Q2 2024	$32,435,000			30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$32,812,000			31 Mar 2024	10-Q	08 May 2024	2024	Q1
Q4 2023	$33,520,000	+$2,576,000	+8.3%	31 Dec 2023	10-K	26 Feb 2025	2024	FY
Q3 2023	$5,500,000			31 Oct 2023	10-K	28 Feb 2024	2023	FY
Q4 2022	$30,944,000			31 Dec 2022	10-K	28 Feb 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.